Core Laboratories CLB Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Business | ||||||
| Corporate And Other | -$147K-75.0% | -$159K-101% | -$120K+24.5% | -$87K-129% | -$84K-37.7% | |
| Operating Segment Production Enhancement | $39.87M-6.6% | $45.97M+8.3% | $46.3M+1.6% | $43.88M-1.0% | $42.69M-6.0% | |
| Operating Segment Reservoir Description | $81.93M+1.3% | $92.28M+6.3% | $88.22M-0.7% | $86.28M0.0% | $80.9M-4.0% | |
| Other Operating Income Expense Net by Business | ||||||
| Corporate And Other | $463K-43.0% | $399K— | $406K+729% | $412K+24.1% | $812K+155% | |
| Operating Segment Production Enhancement | $131K+124% | $427K+171% | $306K+278% | $90K-48.3% | -$539K-170% | |
| Operating Segment Reservoir Description | $431K+120% | $470K-91.9% | $5.23M+25.8% | $2.47M+8.8% | -$2.13M-213% | |
| Operating Income by Business | ||||||
| Corporate And Other | -$63K-111% | $0-100% | -$25K-130% | -$60K-137% | $575K+458% | |
| Operating Segment Production Enhancement | $804K-46.5% | $3.03M— | $4.38M+35.5% | $3.15M-28.5% | $1.5M-4.6% | |
| Operating Segment Reservoir Description | $1.15M-51.0% | $12.82M-23.0% | $16.57M+0.5% | $12.2M+6.6% | $2.34M-66.1% | |
| Total Assets by Business | ||||||
| Corporate And Other | $113.25M-4.4% | $111.06M-6.0% | $126.09M+2.1% | $133.05M+7.9% | $118.51M-3.9% | |
| Operating Segment Production Enhancement | $141.14M-5.5% | $140.96M-5.7% | $143.22M-7.6% | $146.91M-9.0% | $149.3M-7.5% | |
| Operating Segment Reservoir Description | $333.34M+4.7% | $331.98M+4.6% | $322.05M0.0% | $322.16M+2.9% | $318.44M+1.7% | |
| Cost of Goods Sold by Business | ||||||
| Corporate And Other | $337K+227% | $244K+135% | $192K+184% | $385K+89.7% | $103K-32.2% | |
| Operating Segment Production Enhancement | $33.63M-3.3% | $38.7M-2.5% | $37.55M-2.4% | $36.38M+2.8% | $34.76M-9.3% | |
| Operating Segment Reservoir Description | $68.11M+5.4% | $70.57M+5.1% | $67.16M-2.0% | $66.94M-0.6% | $64.61M-2.3% | |
| Segment Expenditure Addition To Long Lived Assets by Business | ||||||
| Corporate And Other | $76K+171% | $39K-13.3% | $142K+390% | $0-100% | $28K+1,300% | |
| Operating Segment Production Enhancement | $306K-72.9% | $316K-21.8% | $183K-57.1% | $575K+115% | $1.13M+413% | |
| Operating Segment Reservoir Description | $4.51M+86.2% | $3.3M-16.1% | $2.71M+19.0% | $3.75M+57.9% | $2.42M-14.4% | |
| General And Administrative Expense by Business | ||||||
| Corporate And Other | $0— | $0— | $0— | $0— | $0— | |
| Operating Segment Production Enhancement | $4.75M+3.0% | $3.73M+9.9% | $3.79M+22.2% | $3.65M+3.7% | $4.61M+9.0% | |
| Operating Segment Reservoir Description | $9.97M+10.3% | $6.9M+21.3% | $6.9M+24.5% | $6.82M+1.1% | $9.04M+19.6% | |
| Foreign Currency Transaction Gain Loss Before Tax by Business | ||||||
| Corporate And Other | -$42K+16.0% | -$12K-120% | -$119K-240% | $0-100% | -$50K-2,400% | |
| Operating Segment Production Enhancement | $140K+158% | —— | $76K-35.0% | $182K+258% | -$242K-537% | |
| Operating Segment Reservoir Description | -$478K-154% | —— | -$311K-298% | -$189K+45.4% | -$188K+23.3% | |
| D&A by Business | ||||||
| Corporate And Other | $0— | $0— | $0— | $0— | $0— | |
| Operating Segment Production Enhancement | $985K-10.6% | $990K-9.4% | $1M-5.5% | $1.03M-3.6% | $1.1M+2.1% | |
| Operating Segment Reservoir Description | $2.78M+6.3% | $2.68M+4.2% | $2.59M-0.9% | $2.65M-2.3% | $2.62M-5.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Core Laboratories break its business down?
- Core Laboratories (CLB) reports revenue by business across 3 parts — Corporate And Other, Operating Segment Production Enhancement and Operating Segment Reservoir Description. Each is extracted from the segment footnotes and tracked over time.
- Where does Core Laboratories's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Core Laboratories's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
